Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

FDA actively reviewing TOBI

Oct. 13, 1997

Mutual Recognition Procedure concludes for Nasonex

Oct. 13, 1997

Vanguard Medica and Abbott collaborate on development of new oral asthma therapy

Oct. 13, 1997

PathoGenesis receives grant for new antibiotic for CF infections

Oct. 10, 1997

Patent issued for Fluorovent technology

Oct. 10, 1997

SciClone awarded grant for clinical development of cystic fibrosis therapy

Oct. 10, 1997

Glutarimide tachykinin antagonists reported by Pfizer

Oct. 9, 1997

Genetic basis of asthma becoming clearer, researchers report

Oct. 8, 1997

SB-207499: a second-generation PDE IV inhibitor from SmithKline Beecham

Oct. 8, 1997

Leukotriene antagonists useful for asthma claimed by Bayer

Oct. 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...